Answers are grounded in this paper and cite their sources.
Shows that everolimus-related interstitial lung disease does not affect treatment decisions in metastatic breast cancer, suggesting potential for ongoing therapy.
e-rILD may not influence the choice of following treatment or the development of drug-related ILD during subsequent treatments.
No takes yet. Share an insight, caveat, or question.
Kiyohara et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: